Sorrento Therapeutics
SRNEQ
$0.03000
Share price
3.45%
Change (1 day)
-85.00%
Change (1 year)
Categories
Earnings for Sorrento Therapeutics (SRNEQ)
Earnings in 2023 (TTM): -$0.55 B
According to Sorrento Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.55 B. In 2022 the company made an earning of -$0.56 B a decrease over its 2021 earnings that were of -$0.46 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Sorrento Therapeutics from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.55 B | -1.29% |
| 2022 | -$0.56 B | 22.3% |
| 2021 | -$0.46 B | 52.97% |
| 2020 | -$0.3 B | -8.58% |
| 2019 | -$0.33 B | 107.13% |
| 2018 | -$0.16 B | -775.44% |
| 2017 | $23.11 M | -140.09% |
| 2016 | -$57.68 M | 376.31% |
| 2015 | -$12.11 M | -65.14% |
| 2014 | -$34.73 M | 60.36% |
| 2013 | -$21.66 M | 346.8% |
| 2012 | -$4.85 M | 49.49% |
| 2011 | -$3.25 M | 78.93% |
| 2010 | -$1.82 M | |
| 2008 | -$0.2 M | -20.83% |
| 2007 | -$0.25 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI | -$0.12 B | -78.22% | 🇺🇸 USA |
 Exelixis EXEL | $0.25 B | -147.34% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -$0.12 B | -78.45% | 🇺🇸 USA |